Assignee
ETHERNA IMMUNOTHERAPIES NV
BE·1 granted patent·18 pending applications·2 citations·filing 2019–2023
Top patents by PatentIndex Score
19 records- 0170US11684577B2Lipid nanoparticlesETHERNA IMMUNOTHERAPIES NV·Filed 2019·Granted Jun 27, 2023·2 cites·16 claims
- 0256US2024016738A1Lipid nanoparticlesETHERNA IMMUNOTHERAPIES NV·Filed 2023·Application pending·0 cites
- 0348US2023071518A1INTRANASAL mRNA VACCINESETHERNA IMMUNOTHERAPIES NV·Filed 2021·Application pending·0 cites
- 0446US2025352640A1Multi-epitope constructETHERNA IMMUNOTHERAPIES NV·Filed 2023·Application pending·0 cites
- 0545US2025041394A1Immunostimulatory mrna compositions and uses thereofETHERNA IMMUNOTHERAPIES NV·Filed 2022·Application pending·0 cites
- 0642US2025195437A1Continuous spin freeze-drying of nucleic acid containing compositionsETHERNA IMMUNOTHERAPIES NV·Filed 2023·Application pending·0 cites
- 0742US2025326712A1Ionizable lipidsETHERNA IMMUNOTHERAPIES NV·Filed 2023·Application pending·0 cites
- 0841US2025041238A1METHOD FOR LAGRE-SCALE PRODUCTION OF LARGE-SIZE LNPsETHERNA IMMUNOTHERAPIES NV·Filed 2022·Application pending·0 cites
- 0940US2025331513A1Methods for storing mrna compositionsETHERNA IMMUNOTHERAPIES NV·Filed 2022·Application pending·0 cites
- 1040US2022387573A1Combination therapyETHERNA IMMUNOTHERAPIES NV·Filed 2020·Application pending·0 cites
- 1140US2024167068A1Method for rna manufacturingETHERNA IMMUNOTHERAPIES NV·Filed 2022·Application pending·0 cites
- 1239US2025283133A1Method to reduce double stranded rna by-product formationETHERNA IMMUNOTHERAPIES NV·Filed 2022·Application pending·0 cites
- 1338US2022362360A1Mrna formulationETHERNA IMMUNOTHERAPIES NV·Filed 2020·Application pending·0 cites
- 1437US2023174966A1Rna purification methodETHERNA IMMUNOTHERAPIES NV·Filed 2021·Application pending·0 cites
- 1535US2024050574A1Ionizable lipidsETHERNA IMMUNOTHERAPIES NV·Filed 2021·Application pending·0 cites
- 1634US2024261381A1Lipid nanoparticlesETHERNA IMMUNOTHERAPIES NV·Filed 2021·Application pending·0 cites
- 1732US2023067722A1Lipid nanoparticlesETHERNA IMMUNOTHERAPIES NV·Filed 2021·Application pending·0 cites
- 1829US2022143161A1Mrna vaccineETHERNA IMMUNOTHERAPIES NV·Filed 2020·Application pending·0 cites
- 1928US2021386843A1mRNA VaccineETHERNA IMMUNOTHERAPIES NV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ETHERNA IMMUNOTHERAPIES NV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →